Cellectis S.A. ( CLLS) - Stock Earnings
CLLS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
CLLS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -26.3 million USD | 10.4 million USD |
| 2026Q1 | -17.8 million USD | 5.8 million USD |
| 2026Q2 | -21.8 million USD | 5.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CLLS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.1 million USD | 755000 USD |
| 2024 | -36.8 million USD | 41.5 million USD |
| 2025 | -67.6 million USD | 72.9 million USD |
| 2026 Est. | — | — |
CLLS
Price: $1.04
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 1.9 million
Ebitda: -29.3 millionMarket Capitalization: 143.6 million